Infectious mononucleosis

Vetsika EK, Callan M. Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med. 2004 Nov 5;6(23):1-16. Abstract

Katz BZ. Update on chronic fatigue syndrome and Epstein-Barr virus. Pediatr Ann. 2002 Nov;31(11):741-4. Abstract

Ganzel TM, Goldman JL, Padhya TA. Otolaryngologic clinical patterns in pediatric infectious mononucleosis. Am J Otolaryngol. 1996 Nov-Dec;17(6):397-400. Abstract

De Paor M, O'Brien K, Fahey T, et al. Antiviral agents for infectious mononucleosis (glandular fever). Cochrane Database Syst Rev. 2016 Dec 8;(12):CD011487.Full text  Abstract

1. Lajo A, Borque C, Del Castillo F, et al. Mononucleosis caused by Epstein-Barr virus and cytomegalovirus in children: a comparative study of 124 cases. Pediatr Infect Dis J. 1994 Jan;13(1):56-60. Abstract

2. Gershburg E, Pagano JS. Epstein-Barr virus infections: prospects for treatment. J Antimicrob Chemother. 2005 Aug;56(2):277-81.Full text  Abstract

3. Cohen JI. Epstein-Barr virus infection. N Engl J Med. 2000 Aug 17;343(7):481-92. Abstract

4. Bottieau E, Clerinx J, Van den Enden E, at al. Infectious mononucleosis-like syndromes in febrile travelers returning from the tropics. J Travel Med. 2006 Jul-Aug;13(4):191-7.Full text  Abstract

5. Chapman AL, Watkin R, Ellis CJ. Abdominal pain in acute infectious mononucleosis. BMJ. 2002 Mar 16;324(7338):660-1.Full text  Abstract

6. Auwaerter PG. Infectious mononucleosis in middle age. JAMA. 1999 Feb 3;281(5):454-9. Abstract

7. Drebber U, Kasper HU, Krupacz J, et al. The role of Epstein-Barr virus in acute and chronic hepatitis. J Hepatol. 2006 May;44(5):879-85. Abstract

8. Doja A, Bitnun A, Ford Jones EL, et al. Pediatric Epstein-Barr virus-associated encephalitis: 10-year review. J Child Neurol. 2006 May;21(5):384-91. Abstract

9. Connelly KP, DeWitt LD. Neurologic complications of infectious mononucleosis. Pediatr Neurol. 1994 May;10(3):181-4. Abstract

10. Bolis V, Karadedos C, Chiotis I, et al. Atypical manifestations of Epstein-Barr virus in children: a diagnostic challenge. J Pediatr (Rio J). 2016 Mar-Apr;92(2):113-21.Full text  Abstract

11. Luzuriaga K, Sullivan JL. Infectious mononucleosis. N Engl J Med. 2010 May 27;362(21):1993-2000. Abstract

12. Pariente M, Bartolome J, Lorente S, et al. Age distribution of serological profiles of Epstein-Barr virus infection: review of results from a diagnostic laboratory [in Spanish]. Enferm Infecc Microbiol Clin. 2007 Feb;25(2):108-10. Abstract

13. Ternak G, Uj M, Szucs G, et al. Sero-epidemiologic study of Epstein-Barr virus markers in patients without mononucleosis at a department for infectious diseases [in Hungarian]. Orv Hetil. 1995 Dec 10;136(50):2727-30. Abstract

14. Pereira MS, Blake JM, Macrae AD. EB virus antibody at different ages. Br Med J. 1969 Nov 29;4(5682):526-7.Full text  Abstract

15. Kuri A, Jacobs BM, Vickaryous N, et al. Epidemiology of Epstein-Barr virus infection and infectious mononucleosis in the United Kingdom. BMC Public Health. 2020 Jun 12;20(1):912.Full text  Abstract

16. Winter JR, Taylor GS, Thomas OG, et al. Predictors of Epstein-Barr virus serostatus in young people in England. BMC Infect Dis. 2019 Nov 28;19(1):1007.Full text  Abstract

17. Dowd JB, Palermo T, Brite J, et al. Seroprevalence of Epstein-Barr virus infection in U.S. children ages 6-19, 2003-2010. PLoS One. 2013 May 22;8(5):e64921.Full text  Abstract

18. Schuster V, Kreth HW. Epstein-Barr virus infection and associated diseases in children. I. Pathogenesis, epidemiology and clinical aspects. Eur J Pediatr. 1992 Oct;151(10):718-25. Abstract

19. Crawford DH, Macsween KF, Higgins CD, et al. A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis. Clin Infect Dis. 2006 Aug 1;43(3):276-82.Full text  Abstract

20. Takeuchi K, Tanaka-Taya K, Kazuyama Y, et al. Prevalence of Epstein Barr virus in Japan: trends and future prediction. Pathol Int. 2006 Mar;56(3):112-6. Abstract

21. Naito T, Kudo N, Inui A, et al. Causes of infectious mononucleosis-like syndrome in adult patients. Intern Med. 2006;45(13):833-4.Full text  Abstract

22. Hurt C, Tammaro D. Diagnostic evaluation of mononucleosis-like illness. Am J Med. 2007 Oct;120(10):911;e1-8.Full text  Abstract

23. Fafi-Kremer S, Morand P, Brion JP, et al. Long-term shedding of infectious Epstein-Barr virus after infectious mononucleosis. J Infect Dis. 2005 Mar 15;191(6):985-9.Full text  Abstract

24. Yao QY, Rickinson AB, Epstein MA. A re-examination of the Epstein-Barr virus carrier state in healthy seropositive individuals. Int J Cancer. 1985 Jan 15;35(1):35-42. Abstract

25. Higgins CD, Swerdlow AJ, Macsween KF, et al. A study of risk factors for acquisition of Epstein-Barr virus and its subtypes. J Infect Dis. 2007 Feb 15;195(4):474-82.Full text  Abstract

26. Thomas R, Macsween KF, McAulay K, et al. Evidence of shared Epstein-Barr viral isolates between sexual partners, and low level EBV in genital secretions. J Med Virol. 2006 Sep;78(9):1204-9. Abstract

27. Woodman CB, Collins SI, Vavrusova N, et al. Role of sexual behavior in the acquisition of asymptomatic Epstein-Barr virus infection: a longitudinal study. Pediatr Infect Dis J. 2005 Jun;24(6):498-502. Abstract

28. Vetsika EK, Callan M. Infectious mononucleosis and Epstein-Barr virus. Expert Rev Mol Med. 2004 Nov 5;6(23):1-16. Abstract

29. Abbott RJ, Pachnio A, Pedroza-Pacheco I, et al. Asymptomatic primary infection with Epstein-Barr virus: observations on young adult cases. J Virol. 2017 Oct 13;91(21).Full text  Abstract

30. Cohen JI. Vaccine development for Epstein-Barr virus. Adv Exp Med Biol. 2018;1045:477-93.Full text  Abstract

31. Winter JR, Jackson C, Lewis JE, et al. Predictors of Epstein-Barr virus serostatus and implications for vaccine policy: A systematic review of the literature. J Glob Health. 2020 Jun;10(1):010404.Full text  Abstract

32. Rühl J, Leung CS, Münz C. Vaccination against the Epstein-Barr virus. Cell Mol Life Sci. 2020 Nov;77(21):4315-24.Full text  Abstract

33. Fugl A, Andersen CL. Epstein-Barr virus and its association with disease - a review of relevance to general practice. BMC Fam Pract. 2019 May 14;20(1):62.Full text  Abstract

34. Auwaerter PG. Recent advances in the understanding of infectious mononucleosis: are prospects improved for treatment or control? Expert Rev Anti Infect Ther. 2006 Dec;4(6):1039-49. Abstract

35. Rea TD, Russo JE, Katon W, et al. Prospective study of the natural history of infectious mononucleosis caused by Epstein-Barr virus. J Am Board Fam Pract. 2001 Jul-Aug;14(4):234-42.Full text  Abstract

36. Ebell MH, Call M, Shinholser J, et al. Does this patient have infectious mononucleosis?: the rational clinical examination systematic review. JAMA. 2016 Apr 12;315(14):1502-9. Abstract

37. Ebell MH. Epstein-Barr virus infectious mononucleosis. Am Fam Physician. 2004 Oct 1;70(7):1279-87.Full text  Abstract

38. Bruu AL, Hjetland R, Holter E, et al. Evaluation of 12 commercial tests for detection of Epstein-Barr virus-specific and heterophile antibodies. Clin Diagn Lab Immunol. 2000 May;7(3):451-6.Full text  Abstract

39. Bell AT, Fortune B, Sheeler R. Clinical inquiries. What test is the best for diagnosing infectious mononucleosis? J Fam Pract. 2006 Sep;55(9):799-802. Abstract

40. Hess RD. Routine Epstein-Barr virus diagnostics from the laboratory perspective: still challenging after 35 years. J Clin Microbiol. 2004 Aug;42(8):3381-7.Full text  Abstract

41. Smellie WSA, Forth J, Smart SRS, et al. Best practice in primary care pathology: review 7. J Clin Pathol. 2007 May;60(5):458-65.Full text  Abstract

42. Vouloumanou EK, Rafailidis PI, Falagas ME. Current diagnosis and management of infectious mononucleosis. Curr Opin Hematol. 2012 Jan;19(1):14-20. Abstract

43. Niller HH, Bauer G. Epstein-Barr virus: clinical diagnostics. Methods Mol Biol. 2017;1532:33-55.Full text  Abstract

44. Simundic AM, Bölenius K, Cadamuro J, et al. Joint EFLM-COLABIOCLI recommendation for venous blood sampling. Clin Chem Lab Med. 2018;56(12):2015-38. Abstract

45. Mergoum AM. Amoxicillin rash in infectious mononucleosis. N Engl J Med. 2021 Sep 9;385(11):1033.Full text  Abstract

46. Schechter S, Lamps L. Epstein-Barr virus hepatitis: a review of clinicopathologic features and differential diagnosis. Arch Pathol Lab Med. 2018 Oct;142(10):1191-5.Full text  Abstract

47. Kofteridis DP, Koulentaki M, Valachis A, et al. Epstein Barr virus hepatitis. Eur J Intern Med. 2011 Feb;22(1):73-6.Full text  Abstract

48. Katz BZ. Update on chronic fatigue syndrome and Epstein-Barr virus. Pediatr Ann. 2002 Nov;31(11):741-4. Abstract

49. Miller JM, Binnicker MJ, Campbell S, et al. A guide to utilization of the microbiology laboratory for diagnosis of infectious diseases: 2018 update by the Infectious Diseases Society of America and the American Society for Microbiology. Clin Infect Dis. 2018 Aug 31;67(6):e1-94.Full text  Abstract

50. Jiang SY, Yang JW, Shao JB, et al. Real-time polymerase chain reaction for diagnosing infectious mononucleosis in pediatric patients: a systematic review and meta-analysis. J Med Virol. 2016 May;88(5):871-6. Abstract

51. Bauer CC, Aberle SW, Popow-Kraupp T, et al. Serum Epstein-Barr virus DNA load in primary Epstein-Barr virus infection. J Med Virol. 2005 Jan;75(1):54-8. Abstract

52. Shi T, Huang L, Luo L, et al. Diagnostic value of serological and molecular biological tests for infectious mononucleosis by EBV in different age stages and course of the disease. J Med Virol. 2021 Jun;93(6):3824-34.Full text  Abstract

53. Merriam SC, Keeling RP. Beta-hemolytic streptococcal pharyngitis: uncommon in infectious mononucleosis. South Med J. 1983 May;76(5):575-6. Abstract

54. Hoagland RJ. Infectious mononucleosis. Prim Care. 1975 Jun;2(2):295-307. Abstract

55. Ganzel TM, Goldman JL, Padhya TA. Otolaryngologic clinical patterns in pediatric infectious mononucleosis. Am J Otolaryngol. 1996 Nov-Dec;17(6):397-400. Abstract

56. Leach TC, Sumaya CV. Epstein-Barr virus. In: Feigin RD, Cherry J, Demmel G, et al., eds. Textbook of pediatric infectious diseases. 5th ed. Philadelphia, PA: WB Saunders; 2003:1932-48.

57. Walter RB, Hong TC, Bachli EB. Life-threatening thrombocytopenia associated with acute Epstein-Barr virus infection in an older adult. Ann Hematol. 2002 Nov;81(11):672-5. Abstract

58. Roy M, Bailey B, Amre DK, et al. Dexamethasone for the treatment of sore throat in children with suspected infectious mononucleosis: a randomized, double-blind, placebo-controlled, clinical trial. Arch Pediatr Adolesc Med. 2004 Mar;158(3):250-4.Full text  Abstract

59. Rezk E, Nofal YH, Hamzeh A, et al. Steroids for symptom control in infectious mononucleosis. Cochrane Database Syst Rev. 2015 Nov 8;(11):CD004402.Full text  Abstract

60. Webster J, Osborne S, Rickard CM, et al. Clinically-indicated replacement versus routine replacement of peripheral venous catheters. Cochrane Database Syst Rev. 2019 Jan 23;(1):CD007798.Full text  Abstract

61. Cyran EM, Rowe JM, Bloom RE. Intravenous gammaglobulin treatment for immune thrombocytopenia associated with infectious mononucleosis. Am J Hematol. 1991 Oct;38(2):124-9. Abstract

62. Provan D, Stasi R, Newland AC, et al. International consensus report on the investigation and management of primary immune thrombocytopenia. Blood. 2010 Jan 14;115(2):168-86.Full text  Abstract

63. De Paor M, O'Brien K, Fahey T, et al. Antiviral agents for infectious mononucleosis (glandular fever). Cochrane Database Syst Rev. 2016 Dec 8;(12):CD011487.Full text  Abstract

64. Torre D, Tambini R. Acyclovir for treatment of infectious mononucleosis: a meta-analysis. Scand J Infect Dis. 1999;31(6):543-7. Abstract

65. Rafailidis PIM. Antiviral treatment for severe EBV infections in apparently immunocompetent patients. J Clin Virol. 2010 Nov;49(3):151-7. Abstract

66. Ma C, Wong KC, Wong BCK, et al. Cytokine responses in a severe case of glandular fever treated successfully with foscarnet combined with prednisolone and intravenous immunoglobulin. J Med Virol. 2009 Jan;81(1):99-105. Abstract

67. Balfour HH, Hokanson KM, Schacherer RM, et al. A virologic pilot study of valacyclovir in infectious mononucleosis. J Clin Virol. 2007 May;39(1):16-21. Abstract

68. Adams LA, Deboer B, Jeffrey G, et al. Gancyclovir and the treatment of Epstein-Barr virus hepatitis. J Gastroenterol Hepatol. 2006 Nov;21(11):1758-60. Abstract

69. Yager JE, Magaret AS,3, Kuntz SR, et al. Valganciclovir for the suppression of Epstein-Barr virus replication. J Infect Dis. 2017 Jul 15;216(2):198-202.Full text  Abstract

70. La Mantia I, Varricchio A, Andaloro C, et al. Pidotimod in children with infectious mononucleosis: a preliminary randomized controlled study. J Biol Regul Homeost Agents. 2020 Jul-Aug;34(4):1597-9.Full text  Abstract

71. Zhang L, Goudth J, Christmas D, et al. Microbial infections in eight genomic subtypes of chronic fatigue syndrome/myalgic encephalomyelitis (CFS/ME). J Clin Pathol. 2010 Feb;63(2):156-64.Full text  Abstract

72. Lerner AM, Beqaj SH, Deeter RG, et al. Valacyclovir treatment in Epstein-Barr virus subset chronic fatigue syndrome: thirty-six months follow-up. In Vivo. 2007 Sep-Oct;21(5):707-13.Full text  Abstract

73. Kogelnik AM, Loomis K, Hoegh-Peterson M, et al. Use of valganciclovir with elevated antibody titers against Human herpesvirus-6 (HHV-6) and Epstein-Barr virus (EBV) who were experiencing central nervous system dysfunction including long-standing fatigue. JJ Clin Virol. 2006 Dec;37(suppl 1):S33-8. Abstract

74. Hickie I, Davenport T, Wakefield D, et al. Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study. BMJ. 2006 Sep 16;333(7568):575.Full text  Abstract

75. Nyland M, Naess H, Birkeland JS, et al. Longitudinal follow-up of employment status in patients with chronic fatigue syndrome after mononucleosis. BMJ Open. 2014 Nov 26;4(11):e005798.Full text  Abstract

76. Thompson DF, Ramos CL. Antibiotic-induced rash in patients with infectious mononucleosis. Ann Pharmacother. 2017 Feb;51(2):154-62. Abstract

77. Farley DR, Zietlow SP, Bannon MP, et al. Spontaneous rupture of the spleen due to infectious mononucleosis. Mayo Clin Proc. 1992 Sep;67(9):846-53. Abstract

78. Bartlett A, Williams R, Hilton M. Splenic rupture in infectious mononucleosis: a systematic review of published case reports. Injury. 2016 Mar;47(3):531-8. Abstract

79. Stephenson JT, DuBois JJ. Nonoperative management of spontaneous splenic rupture in infectious mononucleosis: a case report and review of the literature. Pediatrics. 2007 Aug;120(2):e432-5. Abstract

80. Heo DH, Baek DY, Oh SM, et al. Splenic infarction associated with acute infectious mononucleosis due to Epstein-Barr virus infection. J Med Virol. 2017 Feb;89(2):332-6. Abstract

81. Ali K, Lawthom C. Epstein-Barr virus-associated cerebellar ataxia. BMJ Case Rep. 2013 Apr 22;2013.Full text  Abstract

82. Fernandez-Pol S, Silva O, Natkunam Y. Defining the elusive boundaries of chronic active Epstein-Barr virus infection. Haematologica. 2018 Jun;103(6):924-7.Full text  Abstract

83. Kimura H, Hoshino Y, Kanegane H, et al. Clinical and virologic characteristics of chronic active Epstein-Barr virus infection. Blood. 2001 Jul 15;98(2):280-6.Full text  Abstract

84. Thacker EL, Mirzaei F, Ascherio A. Infectious mononucleosis and risk for multiple sclerosis: a meta-analysis. Ann Neurol. 2006 Mar;59(3):499-503. Abstract

85. Sheik-Ali S. Infectious mononucleosis and multiple sclerosis - updated review on associated risk. Mult Scler Relat Disord. 2017 May;14:56-9. Abstract

86. Belbasis L, Bellou V, Evangelou E, et al. Environmental factors and risk of multiple sclerosis: findings from meta-analyses and Mendelian randomization studies. Mult Scler. 2020 Apr;26(4):397-404.Full text  Abstract

87. Jacobs BM, Giovannoni G, Cuzick J, et al. Systematic review and meta-analysis of the association between Epstein-Barr virus, multiple sclerosis and other risk factors. Mult Scler. 2020 Oct;26(11):1281-97.Full text  Abstract

88. Houen G, Trier NH. Epstein-Barr virus and systemic autoimmune diseases. Front Immunol. 2020;11:587380.Full text  Abstract

89. Li ZX, Zeng S, Wu HX, et al. The risk of systemic lupus erythematosus associated with Epstein-Barr virus infection: a systematic review and meta-analysis. Clin Exp Med. 2019 Feb;19(1):23-36.Full text  Abstract

90. Bakkalci D, Jia Y, Winter JR, et al. Risk factors for Epstein Barr virus-associated cancers: a systematic review, critical appraisal, and mapping of the epidemiological evidence. J Glob Health. 2020 Jun;10(1):010405.Full text  Abstract

91. Kanda T, Yajima M, Ikuta K. Epstein-Barr virus strain variation and cancer. Cancer Sci. 2019 Apr;110(4):1132-9.Full text  Abstract

92. Candy B, Chalder T, Cleare AJ, et al. Recovery from infectious mononucleosis: a case for more than symptomatic therapy? A systematic review. Br J Gen Pract. 2002 Oct;52(483):844-51.Full text  Abstract

93. White PD, Thomas JM, Amess J, et al. Incidence, risk and prognosis of acute and chronic fatigue syndromes and psychiatric disorders after glandular fever. Br J Psychiatry. 1998 Dec;173:475-81. Abstract

94. Vindegaard N, Petersen LV, Lyng-Rasmussen BI, et al. Infectious mononucleosis as a risk factor for depression: a nationwide cohort study. Brain Behav Immun. 2021 May;94:259-65.Full text  Abstract

95. Kim A, Yang HR, Moon JS, et al. Epstein-Barr virus infection with acute acalculous cholecystitis. Pediatr Gastroenterol Hepatol Nutr. 2014 Mar;17(1):57-60.Full text  Abstract

96. Leganés Villanueva C, Goruppi I, Brun Lozano N, et al. Acute acalculous cholecystitis due to a primary Epstein Barr virus infection in a pediatric patient. Pediatr Rep. 2021 Feb 6;13(1):86-90.Full text  Abstract

97. Moretti M, Lava SAG, Zgraggen L, et al. Acute kidney injury in symptomatic primary Epstein-Barr virus infectious mononucleosis: systematic review. J Clin Virol. 2017 Jun;91:12-7. Abstract

98. Marsh RA. Epstein-Barr virus and hemophagocytic lymphohistiocytosis. Front Immunol. 2017;8:1902.Full text  Abstract

99. Sevier TL. Infectious disease in athletes. Med Clin North Am. 1994;78:389-412. Abstract